1.A case of dyskeratosis congenita.
Ji Whan HAN ; Jong Woo BAE ; Woo Gun CHOI ; Hack Ki KIM ; Kyong Su LEE
Korean Journal of Hematology 1991;26(2):425-428
No abstract available.
Dyskeratosis Congenita*
2.Two cases of hybrid leukemia.
Sung Dong CHOI ; Dae Chul JUNG ; Woo Gun CHOI ; Hack Ki KIM ; Kyong Su LEE
Journal of the Korean Pediatric Society 1991;34(1):130-136
No abstract available.
Leukemia*
4.A clinical study of childhood acute mixed lineage leukemia.
Kwang Kook MIN ; Young Woo KIM ; Woo Gun CHOI ; Hack Ki KIM ; Ik Jun LEE ; Kyong Su LEE
Korean Journal of Hematology 1993;28(2):365-371
No abstract available.
Leukemia*
5.Treatment of severe aplastic anemia: comparison between bone marrow transplantation and immunomodulation.
Dae Chul JEONG ; Sung Dong CHOI ; Woo Gun CHOI ; Hack Ki KIM ; Kyong Su LEE ; Du Bong LEE
Journal of the Korean Pediatric Society 1991;34(2):172-179
No abstract available.
Anemia, Aplastic*
;
Bone Marrow Transplantation*
;
Bone Marrow*
;
Immunomodulation*
6.Glycated Hemoglobin and All-Cause Mortality in Korean Type 2 Diabetes
Mi Suk AN ; Sun A KIM ; Jun Ho LEE ; Seong Woo CHOI ; Min Ho SHIN
Chonnam Medical Journal 2017;53(3):223-228
The purpose of this study was to evaluate the association between glycated hemoglobin (HbA1c) and all-cause mortality in type 2 diabetes mellitus. We conducted a community-based prospective cohort study of 352 type 2 diabetic patients aged 30-92 who participated in a community diabetes complications screening program in Gokseng-gun, Jeollanamdo, Korea. HbA1c levels were categorized as <6.5%, 6.5-6.9%, 7.0-7.9%, 8.0-8.9% and ≥9.0%. Patients were followed up on for a mean of 6.9 years. The Cox proportional hazards model was used to evaluate the relationship between HbA1c levels and all-cause mortality. During the mean follow-up period of 6.9 years, 77 patients (21.9%) died. A J-shaped association was found between HbA1c and all-cause mortality, with the lowest mortality at 6.5-6.9% of HbA1c levels. Compared to patients with HbA1c of 6.5-6.9%, patients with <6.5%, 7.0-7.9%, 8.0-8.9% and ≥9.0% had an adjusted hazard ratio (95% confidence interval) for all-cause mortality of 1.71 (0.76-3.84), 1.23 (0.53-2.82), 1.32(0.51-3.44) and 2.66 (1.01-7.02), respectively. We found a J-shaped association between glycated hemoglobin and all-cause mortality in Korean type 2 diabetic patients.
Cohort Studies
;
Diabetes Complications
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2
;
Follow-Up Studies
;
Hemoglobin A, Glycosylated
;
Humans
;
Jeollanam-do
;
Korea
;
Mass Screening
;
Mortality
;
Proportional Hazards Models
;
Prospective Studies
7.The Clinical Efficacy of Amniotic Membrane Transplantation and Limbal-Conjunctival Autograft in Patients with Recurrent Pterygium or Pseudopterygium.
Gun Sic PARK ; Tae Hoon CHOI ; Woo Chan PARK ; Jae Chan KIM
Journal of the Korean Ophthalmological Society 2001;42(8):1143-1149
PURPOSE: To evaluate the clinical efficacy of amniotic membrane transplantation and limbal-conjunctival autograft for patients with recurrent pterygium or pseudopterygium, the results of 15 eyes of 14 patients were analyzed. METHODS: Total 10 cases of recurrent pterygium and 5 cases of pseudopterygium were surgically managed during June 1998 to July 2000. After excision of pterygium, amniotic membrane was attached on the bare sclera and limbal-conjunctival autograft was transplanted over the amniotic membrane. Mean follow-up period was 47.2 week and all patients were examined for recurrence, which was graded from G0(no vessel) to G3(fibrotic tissue invading the limbus). RESULTS: 12 out of 15 cases(rate 80%) showed no recurrence(grade 0). 1 case of grade 2 recurrence and 2 cases of grade 3(total 3 cases) were observed(rate 20%). Reoperation was performed on 2 cases of grade 3 recurrence. There was no further recurrence necessitating additional reoperation. 1 case of limbal graft was detached and removed. The operation time of this more prolonged than the other procedures, but there were no significant complications. CONCLUSION: Amniotic membrane and limbal-conjunctival autograft for patients with recurrent pterygium or pseudopterygium reconstructed complete ocular surface with less recurrence. Therefore, we recommend this surgical approach as a safe and effective method for the treatment of complicated cases of pterygium.
Amnion*
;
Autografts*
;
Follow-Up Studies
;
Humans
;
Pterygium*
;
Recurrence
;
Reoperation
;
Sclera
;
Transplants
8.Raeder's Syndrome.
Kab Jin KIM ; Jae Woo KIM ; Ki Jong CHOI ; Sang Gun LEE
Journal of the Korean Neurological Association 1995;13(2):403-408
Raeder's syndrome, or Raeder's paratrigeminal syndrome, is a painful Horner's syndrome characterized by unilateral head pain, oculosympathetic paralysis (miosis, ptosis) and anhydrosis over the forehead with otherwise normal facial sweating. We report two cases of Raeder's syndrome whose cause had not been found despite of intensive investigation and one case associated with nasopharyngeal tumor. The first case had a headache, miosis, ptosis but had not cranial nerve palsy. The second case had a unilateral facial headache, oculosympathetic paralysis, aoydrosis of forehead and sensory change in the ipsilateral ophthalmic division of the trigeminal nerve. The third case had a headache, miosis, ptosis, anhydrosis of forehead and sensory change in the whole territory of the trigeminal nerve.
Cranial Nerve Diseases
;
Forehead
;
Headache
;
Horner Syndrome
;
Miosis
;
Paralysis
;
Sweat
;
Sweating
;
Trigeminal Nerve
9.Immunomodulation Therapy in Children with Aplastic Anemia.
Won Suk SUH ; Ki Sik MIN ; Woo Gun CHOI ; Hack Ki KIM ; Kyoung Sn LEE ; Soon Yong LEE
Journal of the Korean Pediatric Society 1990;33(2):170-177
No abstract available.
Anemia, Aplastic*
;
Child*
;
Humans
;
Immunomodulation*
10.Intermittent central nervous system irradiation and intrathecal chemotherapy for recurrent central nervous system leukemia in children.
Joon Ho BANG ; Nak gyun CHUNG ; Woo Gun CHOI ; Hack Ki KIM ; Kyong Su LEE ; Man Kyu YANG
Journal of the Korean Pediatric Society 1993;36(8):1067-1072
Between 1986 and 1990, four children with recurrent CNS leukemia who had previous CNS prophylaxis therapy were treated with intermittent central nervous system irradiation and intrathecal chemotherapy (IIIC). There was no isolated CNS recurrence. One patient died form bone marrow relapse. Three patients are alive without evidence of disease for 3E3/12 year to 3E6/12 year after the diagnosis of recurrence of CNS leukemia. This experience suggests that IIIC may be an effective treatment for preventing the recurrence of CNS leukemia without any serious side effects.
Bone Marrow
;
Central Nervous System*
;
Child*
;
Diagnosis
;
Drug Therapy*
;
Humans
;
Leukemia*
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Recurrence